However, it is crucial to understand that this comparison addresses safety profiles only, not therapeutic equivalence
This GH/IGF-1 axis drives several key metabolic effects: Increased lipolysis, particularly in visceral fat Improved mitochondrial function Enhanced muscle protein synthesis Reduced hepatic fat accumulation Improved insulin signaling Crucially, tesamorelin preferentially reduces visceral fat , not subcutaneous fat
The origins of these symptoms are unclear, but they may be related to the stomach inflammation underlying some cases of vitamin B 12 deficiency and to the progressive destruction of the lining of the stomach (21)
However, AOD 9604 works as a result of triggering pathways that naturally promote the metabolism of fat in areas like the abdomen, hips and thighs, which are known to be stubborn
Its a game-changer for your metabolic health